"There is no reason anyone would want a computer in their home."
Ken Olsen, chairman and founder of Digital Equipment Corporation ; 1977
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8183386 | Phenylnaphthylimidazole compound and usage of the same A surface treating agent containing a novel phenylnaphthylimidazole compound represented by the following formula is brought into contact with the surface of copper or a copper alloy. In the formula, when A1 is a p... | 05/22/2012 |
| 8008504 | Process for the synthesis of organic compounds The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (II): | 08/30/2011 |
| 7781597 | Process for the synthesis of organic compounds The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (II): | 08/24/2010 |
| 7687640 | Cinnamide compound The present invention relates to a process for preparing a compound of formula (6a): wherein Ar1 represents an imidazolyl group which may be substituted with 1 to 3 substituents shown below; Ar2 repres... | 03/30/2010 |
| 7402602 | Imidazole derivatives modulating the sodium channels A method of treating cardiac rhythm disorders linked with neurodegenerating depression, bipolar disorders and irritable bowel disorders in warm-blooded animals in need thereof by administering a compound of the formula wher... | 07/22/2008 |
| 7320995 | Benzimidazoles and benzothiazoles as inhibitors of map kinase The present invention provides kinase inhibitors of Formula I: wherein W represents inter alia imidazol, oxazol, pyrazol, thiazol as triazol, which are substituted by phenyl or thienyl. The disclosed compounds inhibit p-38 kinase and are useful in the treatment of m... | 01/22/2008 |
| 7297708 | Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands Provided herein are novel heteroaromatic substituted cyclopropanes of the Formula (I): as well as compositions, including pharmaceutical compositions, containing the same, and the use thereof in the treatment of various neurologi... | 11/20/2007 |
| 7235320 | Proton-conducting membrane and use thereof The present invention relates to a novel proton-conducting polymer membrane based on polyazoles which can, because of its excellent chemical and thermal properties, be used in a variety of ways and is particularly useful as polymer electrolyte membrane (PEM) to prod... | 06/26/2007 |
| 7223781 | 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors The invention relates to the 2-mercapto-4,5-diarylimidazole derivatives of formula (I), wherein R1, R2, R3 and R4 are defined as in the description. The inventive compounds have an immunomodulatory and cyclooxygenase-inhib... | 05/29/2007 |
| 7186742 | Benzamide inhibitors of the P2Xreceptor The present invention provides benzamide inhibitors of the P2X7 receptor of the formula: wherein R1–R3 are as defined herein. The compounds of the invention are useful in the tr... | 03/06/2007 |
| 7157483 | Imidazole derivatives modulating the sodium channels A method of modulating, sodium channels in warm-blooded animals in need thereof by administering a compound of the formula Wherein the substituents are defined as in the specification and compounds of the formula... | 01/02/2007 |
| 7115646 | Cyclic diamines and derivatives as factor Xa inhibitors The present application describes cyclic diamino compounds, derivatives thereof, and pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa. ... | 10/03/2006 |
| 6998415 | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase, such as inflammation. ... | 02/14/2006 |
| RE38962 | Diphenyl-triazole derivatives and their use as anti-gestative immuno-suppressant and anti-tumoral agents Compounds of formula (I), wherein X and Y are independently carbon or nitrogen but not both simultaneously carbon, R1 is a group (II) and R2 is a group (III), R5 being a carbonate, carbamate or phosphate residue, are useful as anti-g... | 01/31/2006 |
| 6982259 | N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the following formula: where m, n, p, A1, R1, R2, R3 and R4 are described herein, as well as other N-heterocyclic derivatives, are us... | 01/03/2006 |
| 6972336 | N-alkylation of indole derivatives The present invention provides methods for the efficient preparation of indole derivatives of the formula wherein X is methyl or benzyl; and R1, R2, R3 and R4 are independent... | 12/06/2005 |
| 6956050 | Imidazole compounds as anti-inflammatory and analgesic agents This invention provides a compound of the formula (I): wherein: R1 represents a hydrogen atom, an alkyl group, etc.; R2 represents a hydrogen atom, a halogen atom, etc.; R3 | 10/18/2005 |
| 6841673 | N-heterocyclic derivatives as nos inhibitors N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using the... | 01/11/2005 |
| 6787552 | PPAR delta activators Compounds of the general formula (I) or salts thereof and activators of PPARδ (peroxisome proliferator activated receptor δ) containing the compounds or the salts as the active ingredient: wherein R1 and R2 each are hydrogen, C1-8 ... | 09/07/2004 |
| 6784183 | Diphenylurea compounds Compounds of formula (I): and medicinal products containing the same which are useful as dual α2/5-HT2c antagonists. ... | 08/31/2004 |
| 6673941 | Disubstituted imidazoles useful in the treatment of bacterial infections Compounds of formula (I) and formula (II) are disclosed which are useful in the treatment bacterial infections: ##STR1## wherein: R1 is C1-4 alkyl, Ar or 2-thienyl or 3-thienyl; R2 is C1-4 alkyl or Ar; and ... | 01/06/2004 |
| 6620529 | Materials for light emitting devices and light emitting devices using the same A compound represented by general formula (113): ##STR1## wherein R1 and R2 each represents a hydrogen atom, an aliphatic hydrocarbon group, an aryl group or a heterocylic group; Z1 represents an atomic group necessary to ... | 09/16/2003 |
| 6596877 | Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols An accelerated process for preparing an O-methyl phenol comprising reacting a phenol with dimethyl carbonate in the presence of a catalyst selected from 1,8-diazabicyclo[5.4.0]undec-7-ene; 1,4-diazabicyclo[2.2.2]octane; and dimethylaminopyridine. Accordin... | 07/22/2003 |
| 6562542 | Image-forming material and novel sulfonic acid ester derivative An image-forming material is described, comprising on an support an acid-generating agent selected from a sulfonic acid ester of a specific structure generating an acid by the action of heat and the polymer thereof, and a compound causing a light absorpti... | 05/13/2003 |
| 6559172 | Disubstituted imidazoles useful in the treatment of bacterial infections Novel disubstituted imidazoles are disclosed which are useful in the treatment of bacterial infections, particularly through the inhibition of FAB I.... | 05/06/2003 |
| 6541639 | Efficient ligand-mediated Ullmann coupling of anilines and azoles The present invention provides of method of preparing phenyl-substituted azoles. This method uses an efficient ligand-accelerated Ullmann coupling reaction of anilines with azoles. The coupling products are useful for preparing factor Xa inhibitors.... | 04/01/2003 |
| 6524770 | Hexaaryl biimidazole compounds as photoinitiators, photosensitive composition and method of manufacturing patterns using the compounds A hexaaryl biimidazole compound useful as a photoinitiator, represented by Formula (I): ##STR1## wherein each R group represents an alkyl group which may be the same or different, and each X group is independently a fluorine or hydrogen. The compound... | 02/25/2003 |
| 6515133 | Pharmaceutical compositions containing certain diarylimidazole derivatives Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. Many of the compounds are nove... | 02/04/2003 |
| 6514966 | Compounds for the treatment of obesity NPY antagonists, methods of using such NPY antagonists and pharmaceutical compositions containing such NPY antagonists. The NPY antagonists are useful for the treatment of NPY mediated disease/conditions including obesity.... | 02/04/2003 |
| 6489365 | Amidine derivatives, the preparation and use thereof as medicaments with Itb4 antagonistic effect Compounds of the formula ##STR1## which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.... | 12/03/2002 |
| 6426360 | 4,5-substituted imidazolyl compounds for the treatment of inflammation A class of compounds is described for treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula ##STR1## wherein R1 is selected from lower alkyl, lower haloalkyl, lower hydroxyalkyl, ... | 07/30/2002 |
| 6407257 | Derivatives of erythromycin, their preparation process and their use as medicaments A subject of the invention is, as new chemical products, the compounds of formula (I) ##STR1## in which X represents a hydrogen atom or a halogen atom and Z represents a hydrogen atom or the remainder of an acid as well as their addition salts with a... | 06/18/2002 |
| 6358955 | Substituted imidazoles as subtype specific dopamine receptor ligands and pharmaceutical compositions containing such substituted imidazole Disclosed are compounds of the formula: ##STR1## wherein R1 represents optionally substituted aryl, heteroaryl, arylalkyl, or cycloalkyl groups; X, Z, and Y are optionally substituted nitrogen or carbon atoms; R3 and R4 ar... | 03/19/2002 |
| 6353136 | Process for preparing aromatic amines in the presence of palladaphosphacyclobutane catalysts Aromatic amines of the formula (I) Ar--[NR6 R7 ]n (I) are prepared by reacting a haloaromatic of the formula (II) Ar--Hal (II) with an amine of the formula (III) R6 R7 NH (III) in the presence of a palladaphospha... | 03/05/2002 |
| 6333343 | Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents Compounds of formula (I), wherein X and Y are independently carbon or nitrogen but not both simultaneously carbon, R1 is a group (II) and R2 is a group (III), R5 being a carbonate, carbamate or phosphate residue, are usefu... | 12/25/2001 |
| 6319948 | Retinoid antagonists and uses thereof Retinoid antagonist compounds have been found to be useful in the prevention and/or minimization of surgical adhesion formation. Also provided by the invention are certain novel substituted (5,6)-dihydronaphthalenyl compounds which are retinoid antagonists and... | 11/20/2001 |
| 6271249 | Diphenyl imidazoles as potassium channel modulators Novel compounds of Formula 1 are useful to treat disorders responsive to openers of the large conductance calcium-activated potassium channels: ##STR1## wherein "Het" is one of a select group of heterocyclic moieties; Z is independently for each occurrenc... | 08/07/2001 |
| 6201001 | Imidazole antiproliferative agents Compounds of formula I ##STR1## inhibit celluar proliferation. Processes for the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.... | 03/13/2001 |
| 6177575 | Process for manufacture of imidazoles Imidazoles may be manufactured by reacting a glyoxal, ammonia, an aldehyde, and optionally a primary amine, in the presence of a Bronsted acid whose pKa is approximately equal to the pKa of the ammonium cation of the primary amine, or if the primary amine... | 01/23/2001 |
| 6166221 | Production method of optically active imidazole compound, synthetic intermediate therefor and production method thereof The present invention provides a method for producing an optically active 4-[-hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid or a pharmaceutically acceptable salt thereof, which includes subjecting a compound of the formula (I) w... | 12/26/2000 |